Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) [Phase 2]
Phase 2 study MK-4280A-010 evaluating favezelimab coformulated with pembrolizumab in selected solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations [Phase 1]
ATV-1601, an investigational therapy, is being studied in a Phase 1 trial for patients with AKT1 E17K-mutant cancers, including breast, cerv…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating the cancer response to the combination of abemaciclib and fulvestrant in women with recurrent endometrial cancer ha…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy [NA]
Clinical trial update on perioperative morbidity in gyneco-oncology comparing coelioscopy to robot-assisted coelioscopy. The Centre Oscar La…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating cadonilimab (AK104) in combination with lenvatinib for advanced endometrial cancer; the study is currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Michigan Genetic Hereditary Testing (MiGHT) [NA]
The MiGHT hereditary genetic testing trial at the University of Michigan Rogel Cancer Center has completed, evaluating testing across multip…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]
A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating STRO-004 in adults with refractory or recurrent metastatic cancer is currently recruiting, investigating…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: The LYSA (Linking You to Support and Advice) Trial [NA]
The LYSA trial (NCT05035173) has completed, with conditions listed including survivorship, breast cancer, cervical cancer, and endometrial c…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: PRO1107 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 PRO1107 trial in advanced solid tumors, including endometrial and ovarian cancers, has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers [Phase 1]
The first-in-human Phase 1 study of ATX-559, an oral DHX9 inhibitor from Accent Therapeutics, has been terminated; the trial included patien…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Individual Approach in Gynecological Cancer Brachytherapy [NA]
This completed clinical trial investigated an individualized brachytherapy approach for gynecologic cancers, aiming to optimize radiation de…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the levonorgestrel-releasing intrauterine system with or without everolimus to treat atypical endomet…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the effectiveness of combining DKN-01 (a DKK1 inhibitor) with pembrolizumab in advanced or recurrent endom…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study of PHN-010 in Patients With Advanced Solid Tumors [Phase 1]
PHN-010 Phase 1 trial in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: SLV-154 Treatment of Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SLV-154 evaluating treatment of metastatic solid tumors. The study is currently recruiting across multiple…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas [Phase 2]
Phase 2 trial of sacituzumab govitecan for recurrent platinum-resistant epithelial ovarian cancer, recurrent epithelial endometrial cancer, …
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) [Phase 3]
A Phase 3 clinical trial comparing Sacituzumab Govitecan to physician's choice in endometrial cancer after platinum-based chemotherapy and i…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors [Phase 1]
Phase 1 study of Felmetatug Vedotin (SGN-B7H4V) in advanced solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. [Phase 2]
Phase 2 trial evaluating TQB2450 plus chemotherapy with or without Anlotinib for advanced endometrial cancer or uterine sarcoma was terminat…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase 1 Study of [225Ac]-FPI-1434 Injection [Phase 1]
A Phase 1 study of [225Ac]-FPI-1434 injection sponsored by Fusion Pharmaceuticals has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: ONSD as an ICP Marker in vNOTES and TLH [NA]
Clinical trial evaluating optic nerve sheath diameter as an intracranial pressure marker in vNOTES and TLH for endometrial conditions has co…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Comparison Between High and Low Level Para-aortic Lymphadenectomy in High and Intermediate Risk Endometrial Carcinoma [NA]
The clinical trial comparing high- versus low-level para-aortic lymphadenectomy in high- and intermediate-risk endometrial cancer has comple…